INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol CHANDAN
MSEI Symbol NOTLISTED
ISIN INE0B2N01016
Name of Company Chandan Healthcare Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-02-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 09-02-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Third quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Health Care Sector
Start date and time of board meeting 14-02-2026   16:00:00
End date and time of board meeting 14-02-2026   16:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable


Financial Results — Other than Bank

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-10-2025 01-04-2025
B Date of end of reporting period 31-12-2025 31-12-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Revenue From Operations
Revenue from operations 3,569.71 11,187.64
Other income 67.61 212.71
Total Income 3,637.32 11,400.35
2 Expenses
(a) Cost of materials consumed 322.93 1,676.91
(b) Purchases of stock-in-trade 167.10 432.28
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (7.65) 30.60
(d) Employee benefit expense 1,034.94 2,729.67
(e) Finance costs 93.75 305.55
(f) Depreciation and amortisation expense 236.99 717.75
(g) Other Expenses
1 Other Expenses 1,051.20 2,805.46
Total other expenses 1,051.20 2,805.46
Total expenses 2,899.26 8,698.22
3 Profit before exceptional and extraordinary items and tax 738.06 2,702.13
4 Exceptional items (206.46) (206.46)
5 Profit before extraordinary items and tax 531.60 2,495.67
6 Extraordinary items 0.00 0.00
7 Profit before tax 531.60 2,495.67
8 Tax Expense
Current tax 170.39 607.35
Deferred tax (35.02) 35.93
Total tax expenses 135.37 643.28
9 Net Profit Loss for the period from continuing operations 396.23 1,852.39
10 Profit (loss) from discontinuing operations before tax 0.00 0.00
11 Tax expense of discontinuing operations 0.00 0.00
12 Net profit (loss) from discontinuing operation after tax 0.00 0.00
13 Profit (loss) for period before minority interest 396.23 1,852.39
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 396.23 1,852.39
17 Details of equity share capital
Paid-up equity share capital 2,445.21 2,445.21
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.62 7.58
Diluted earnings (loss) per share from continuing and discontinued operations 1.62 7.58
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-10-2025 01-04-2025
Date of end of reporting period 31-12-2025 31-12-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 17-02-2025
Amount Raised 7,044.64
Report filed for Quarter ended 31-12-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Setting up of a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh N/A 3,281.58 0.00 973.54 0.00
2 Setting up of a new Central Reference laboratory at Ayodhya, Uttar Pradesh N/A 710.23 0.00 710.23 0.00
3 Setting up of a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh N/A 710.11 0.00 710.11 0.00
4 For General Corporate Purpose N/A 1,672.45 0.00 1,672.45 0.00
5 Issue related expenses N/A 670.27 0.00 670.27 0.00


Signatory Details

Name of signatory Rajeev Kumar Nain
Designation of person Company Secretary and Compliance Officer
Place Lucknow
Date 14-02-2026